Prof. Dr. ATİLLA BOZKURT

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behcet's Disease

Goktas M. T., KARACA R. O., KALKISIM S., Cevik L., KILIC L., AKDOĞAN A., et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , cilt.121, sa.4, ss.266-271, 2017 (SCI-Expanded)

EFFECTS OF GENETIC POLYMORPHISMS OF MULTI DRUG RESISTANCE PROTEIN (MDR1) ON LANSOPRAZOLE METABOLISM IN PEDIATRIC PATIENTS

Karaca R. O., Kalkisim S., GÜMÜŞ E., Goktas M. T., YÜCE A., YAŞAR Ü., et al.

DRUG METABOLISM AND PHARMACOKINETICS , cilt.32, sa.1, 2017 (SCI-Expanded)

Investigation of 1377C/T polymorphism of the Toll-like receptor 3 among patients with chronic hepatitis B

Goktas E. F., Bulut C., Goktas M. T., Ozer E. K., Karaca R. O., Kinikli S., et al.

CANADIAN JOURNAL OF MICROBIOLOGY , cilt.62, sa.7, ss.617-622, 2016 (SCI-Expanded)

Relation of the Allelic Variants of Multidrug Resistance Gene to Agranulocytosis Associated With Clozapine

YAGCIOGLU A. E., Yoca G., AYHAN Y., KARACA R. O., Cevik L., MÜDERRİSOĞLU A., et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , cilt.36, sa.3, ss.257-261, 2016 (SCI-Expanded)

mu-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample

GÜREL Ş. C., AYHAN Y., Karaaslan C., Akel H., KARACA R. O., BABAOĞLU M. Ö., et al.

TURK PSIKIYATRI DERGISI , cilt.27, sa.2, ss.75-83, 2016 (SSCI)

Lower CYP2C9 activity in Turkish patients with Beh double dagger et's disease compared to healthy subjects: a down-regulation due to inflammation?

Goktas M. T., Hatta F., KARACA O., KALKISIM S., KILIC L., AKDOĞAN A., et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , cilt.71, sa.10, ss.1223-1228, 2015 (SCI-Expanded)

Improved Anti-Emetic Efficacy of 5-HT3 Receptor Antagonists in Cancer Patients with Genetic Polymorphisms of ABCB1 (MDR1) Drug Transporter

Zoto T., KILIÇKAP S., YAŞAR Ü., ÇELİK İ., BOZKURT A., BABAOĞLU M. Ö.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , cilt.116, sa.4, ss.354-360, 2015 (SCI-Expanded)

Association between ADH1C and ALDH2 polymorphisms and alcoholism in a Turkish sample

AYHAN Y., GÜREL Ş. C., KARACA O., ZOTO T., HAYRAN M., BABAOGLU M., et al.

NORDIC JOURNAL OF PSYCHIATRY , cilt.69, sa.3, ss.233-239, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Quantitative Characterization of Magnetic Mobility of Nanoparticle in Solution-Based Condition

RODOPLU D., BOYACI İ. H., BOZKURT A. G., EKSI H., Zengin A., Tamer U., et al.

CURRENT PHARMACEUTICAL DESIGN , cilt.21, sa.37, ss.5389-5400, 2015 (SCI-Expanded)

INVESTIGATION OF THE ROLE OF ALLELIC VARIANTS OF MULTIDRUG RESISTANCE GENE (MDR1) ON CLOZAPINE RELATED LEUKOPENIA/AGRANULOCYTOSIS

ANIL YAĞCIOĞLU A. E., YOCA G., Karaca R. O., ÇEVİK L., BABAOĞLU M. Ö., AYHAN Y., et al.

SCHIZOPHRENIA RESEARCH , cilt.153, 2014 (SCI-Expanded)

Ocular Pharmacokinetics, Safety and Efficacy of Intracameral Moxifloxacin 0.5% Solution in a Rabbit Model

Akova Y., ASENA L., Goktas M., BOZKURT A., YAŞAR Ü., Karabay G., et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE , cilt.54, sa.15, 2013 (SCI-Expanded)

Ocular Pharmacokinetics, Safety and Efficacy of Intracameral Moxifloxacin 0.5% Solution in a Rabbit Model

ASENA L., Akova Y. A., GÖKTAŞ M. T., BOZKURT A., YAŞAR Ü., Karabay G., et al.

CURRENT EYE RESEARCH , cilt.38, sa.4, ss.472-479, 2013 (SCI-Expanded)

Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood

GÜMÜŞ E., Karaca O., BABAOĞLU M. Ö., BAYSOY G., Balamtekin N., DEMİR H., et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , cilt.68, sa.5, ss.629-636, 2012 (SCI-Expanded)

Effect of Atorvastatin on CYP2C9 Metabolic Activity as Measured by the Formation Rate of Losartan Metabolite in Hypercholesterolaemic Patients

YAŞAR Ü., SAİN GÜVEN G., Yardimci Y., KILIÇARSLAN A., BABAOĞLU M. Ö., BOZKURT A.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , cilt.109, sa.2, ss.73-77, 2011 (SCI-Expanded)

**CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with Schizophrenia**

Balibey H., Basoglu C., Lundgren S., BABAOĞLU M. Ö., YAŞAR Ü., Herken H., et al.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.21, sa.2, ss.93-99, 2011 (SCI-Expanded)

Functional Effects of Endothelial Nitric Oxide Synthase Genetic Polymorphisms on Haemorheological Parameters in Healthy Human Individuals

BABAOĞLU M. Ö., Dikmenoglu N., Ileri-Gurel E., Seringec N., Zoto T., YAŞAR Ü., et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , cilt.108, sa.3, ss.171-176, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Pharmacotherapy resistance in patients undergoing resective epilepsy surgery due to hippocampal sclerosis is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene

Yasar U., Babaoglu M. O., Dericioglu N., Bal B., Bozkurt A., Saygi S.

FUNDAMENTAL & CLINICAL PHARMACOLOGY , cilt.22, ss.51, 2008 (SCI-Expanded)

Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth

GÜNCÜ G. N., ÇAĞLAYAN F., Dincel A., Bozkurt A., ÖZMEN F., KARABULUT E.

AUSTRALIAN DENTAL JOURNAL , cilt.52, sa.4, ss.295-299, 2007 (SCI-Expanded)

Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model

Yagci R., Oflu Y., Dincel A., Kaya E., Yagci S., Bayar B., et al.

EYE , cilt.21, sa.7, ss.990-994, 2007 (SCI-Expanded)

Lens concentration of ofloxacin and lomefloxacin in an experimental endophthalmitis model

Yagci R., Oflu Y., Yagci S., Dincel A., Kaya E., Duman S., et al.

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL , cilt.68, sa.3, ss.184-190, 2007 (SCI-Expanded)

Effect of ocular compression on intraocular penetration of systemic ofloxacin

Ugurbas S. H., Can M., Koksal M., Dincel A., Bozkurt A., Bayar B.

ADVANCES IN THERAPY , cilt.24, sa.2, ss.394-401, 2007 (SCI-Expanded)

Differential alteration of drug-metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patients

Elkiran T., Harputhioglu H., Yasar U., Babaoglu M. O., Dincel A. K., Altundag K., et al.

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY , cilt.29, sa.1, ss.27-32, 2007 (SCI-Expanded)

Plasma and gingival crevicular fluid phenytoin concentrations as risk factors for gingival overgrowth

Guncu G. N., Caglayan F., Dincel A., Bozkurt A., Saygi S., Karabulut E.

JOURNAL OF PERIODONTOLOGY , cilt.77, sa.12, ss.2005-2010, 2006 (SCI-Expanded)

Inhibitory effect of 5-fluorouracil on cytochrome P4502C9 activity in cancer patients

Gunes A., Coskun U., Boruban C., Gunel N., Babaoglu M., Sencan O., et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , cilt.98, sa.2, ss.197-200, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

Association of the ABCB1 3435C > T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists

Babaoglu M., Bayar B., Aynacioglu A., Kerb R., Abali H., Celik I., et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS , cilt.78, sa.6, ss.619-626, 2005 (SCI-Expanded)

**Functional impact of CYP2C5, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans**

Allabi A., Gala J., Horsmans Y., Babaoglu M., Bozkurt A., Heusterspreute M., et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS , cilt.76, sa.2, ss.113-118, 2004 (SCI-Expanded)

Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report

Babaoglu M., Karadag O., Saikawa Y., Altundag K., Elkiran T., Yasar U., et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , cilt.60, sa.6, ss.455-456, 2004 (SCI-Expanded)

CYP2C9 genetic variants and losartan oxidation in a Turkish population

Babaoglu M., Yasar U., Sandberg M., Eliasson E., Dahl M., Kayaalp S., et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , cilt.60, sa.5, ss.337-342, 2004 (SCI-Expanded)

Frequency and enzyme activity of the butyrylcholinesterase K-variant in a Turkish population

Babaoglu M., Ocal T., Bayar B., Kayaalp S., Bozkurt A.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , cilt.59, sa.12, ss.875-877, 2004 (SCI-Expanded)

5-fluorouracil-induced coronary spasm: May inhibition of hyperpolarization factors produced by CYP2C enzymes be the cause?

Karadag O., Babaoglu M., Altundag K., Elkiran T., Yasar U., Bozkurt A.

ONCOLOGY , cilt.66, sa.6, ss.510-511, 2004 (SCI-Expanded)

Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans

Cekic O., Batman C., Yasar U., Basci N. E., Zilelioglu O., Bozkurt A.

BRITISH JOURNAL OF OPHTHALMOLOGY , cilt.84, sa.9, ss.1061-1063, 2000 (SCI-Expanded)

Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes

Ozturk F., Kurt E., Inan U., Kortunay S., Ilker S., Basci N. E., et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.204, ss.91-95, 2000 (SCI-Expanded)

The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats

Erdem A., Gundogan N., Usubutun A., Kilinc K., Erdem S., Kara A., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.15, sa.8, ss.1175-1182, 2000 (SCI-Expanded)

The effects of prolonged acute use and inflammation on the ocular penetration of topical ciprofloxacin

Ozturk F., Kurt E., Inan U., Kortunay S., Ilker S., Basci N. E., et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.204, ss.97-100, 2000 (SCI-Expanded)

The pharmacokinetics and effects of diltiazem in rabbits

Oruc S., Orhan D., Orhan M., Irkec M., Basci N. E., Barun S., et al.

EUROPEAN JOURNAL OF OPHTHALMOLOGY , cilt.10, sa.1, ss.46-50, 2000 (SCI-Expanded)

Optimization of the separation of β-blockers in HPLC

Basci N. E., Temizer A., Bozkurt A., Isimer A.

Journal de Pharmacie de Belgique , cilt.53, sa.3, ss.156, 1998 (SCI-Expanded)

S‐mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.

Basci N. E., Brosen K., Bozkurt A., Isimer A., Sayal A., Kayaalp S.

British Journal of Clinical Pharmacology , cilt.38, sa.5, ss.463-465, 1994 (SCI-Expanded)

Correlation Between the Metabolic Ratios of Debrisoquine and Metoprolol in Turkish Subjects

Basci N. E., Bozkurt A., Isimer A., Kayaalp S.

Pharmacology & Toxicology , cilt.75, sa.1, ss.62-64, 1994 (SCI-Expanded)

N-ACETYLATION PHENOTYPING WITH SULFADIMIDINE IN A TURKISH POPULATION

BOZKURT A., BASCI N. E., KALAN S., TUNCER M., KAYAALP S.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , cilt.38, sa.1, ss.53-56, 1990 (SCI-Expanded)

Comparison of colorimetric and high-performance liquid chromatographic determination of sulphamethoxazole and acetylsulphamethoxazole

Basci N. E., Bozkurt A., Kayaalp S., Isimer A.

Journal of Chromatography B: Biomedical Sciences and Applications , cilt.527, ss.174-181, 1990 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension

Tanrikulu F. P., BABAOĞLU M. Ö., ÇAKIR B., BOZKURT A., Guven G. S.

CUKUROVA MEDICAL JOURNAL , cilt.47, sa.3, ss.1015-1023, 2022 (ESCI)

Endothelial nitric oxide synthase G894T, intron 4 VNTR, and T786C polymorphisms in retinopathy of prematurity

Tekkeşin F., Yurdakok M., GÜMÜŞ E., BABAOĞLU M. Ö., Bozkurt A., Caliskan Kadayifcilar S., et al.

Journal of Neonatal-Perinatal Medicine , cilt.15, sa.2, ss.249-255, 2022 (Scopus)

Penetration of topical ciprofloxacin by presoaked medicated soft contact lenses

Kalayci D., Basci N. E., Kortunay S., Hasiripi H., Bozkurt A.

CLAO Journal , cilt.25, sa.3, ss.182-184, 1999 (Scopus)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Relationship between genetic polymorphisms of multidrug resistance gene MDR1 (ABCB1) and clearance of 99mTc-MIBI

Kapulu-Akca C., Goktas M., Babaoglu M. O., Altundag K., Yasar U., Celik I., et al.

23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Ekim 2010, cilt.37

Association of serotonin transporter gene (SLC6A4) polymorphisms with alcohol dependence in a Turkish population

KARACA O. R., BABAOĞLU M. Ö., YAŞAR Ü., AYHAN Y., GÜREL Ç. S., DILBAZ N., et al.

9th International Meeting of the International-Society-for-the-Study-of-Xenobiotics(ISSX), İstanbul, Türkiye, 4 - 08 Eylül 2010, cilt.42, ss.255-256

Drug transporter gene MDR1 polymorphism C3435T may explain colchicine nonresponsiveness in familial Mediterranean fever

Tufan A., Babaoglu M., Akdogan A., Yasar U., Calguneri M., Kalyoncu U., et al.

Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.100

Differential alteration of drug metabolizing enzyme activities in vivo after cyclophosphamide/doxorubicin administration in operable breast cancer patients.

Elkiran E., Altundag K., Babaoglu M., Yasar U., Ozisik Y., Guler N., et al.

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23

**Effects of CYP2C95,6,8 and 11 polymorphisms on losartan oxidation among black Africans**

Allabi A., Gala J., Horsmans Y., Babaoglu M., Bozkurt A., Heusterspreute M., et al.

8th World Congress of Clinical Pharmacology and Therapeutics, Brisbane, Avustralya, 1 - 06 Ağustos 2004, cilt.31

Tamoxifen inhibits cytochrome P4502C9 activity: A possible mechanism for tamoxifen-warfarin interaction.

Boruban M., Babaoglu M., Sencan O., Bozkurt A., Yasar U.

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22

Metrikler

Yayın

Atıf (WoS)

606

H-İndeks (WoS)

Atıf (Scopus)

406

H-İndeks (Scopus)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler